Digest Network Come funziona
Network
/
Società
Ap
Non verificato

Aptar Pharma

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteSanità

13 comunicati stampa

Guarda tutti i comunicati
28/05/2026
Industria
Sanità
Farmaceutica
Attrezzature medico-sanitarie
Fitness
Medicina - Varie
Scienza
Biotecnologia
Immagazzinaggio/Imballaggio
Salute
Ingegneria
Aptar Pharma Announces New Patent Applications and Preclinical Data Supporting Investigation of Intranasal and Pulmonary GLP-1 Delivery
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
07/05/2026
Eventi
Industria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Salute
Farmaceutica
Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
12/03/2026
Mercato del lavoro
Industria
Sanità
Software
Farmaceutica
Tecnica
HIV, AIDS e malattie autoimmuni
Immagazzinaggio/Imballaggio
Medicina - Varie
Biotecnologia
Salute
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Aptar Pharma Continues Global Expansion with Opening of New R&D Center in France
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
18/09/2025
Aptar Pharma’s Unidose System Delivers Enbumyst™, First U.S. FDA-Approved Intranasal Diuretic
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
05/09/2025
Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
29/07/2025
Aptar’s First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon’s Otrivin® Brand
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
15/07/2025
Scienza
Tecnologia delle costruzioni
Mercato Immobiliare
Medicina - Varie
Biotecnologia
Sanità
Salute
Farmaceutica
Mercato azionario
Industria
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
27/02/2025
RDD Europe 2025, Co-Organized by Aptar Pharma and RDD Online, Celebrates 20 Years
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0
07/11/2024
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Fonte
Aptar Pharma
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0